Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
30 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/bold-therapeutics-presents-late-breaking-poster-on-bold-100s-unique-ability-to-mitigate-oxaliplatin-induced-peripheral-neuropathy-oipn-at-aacr-annual-meeting-2025-302442129.html
28 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/bold-therapeutics-announces-presentation-of-late-breaking-data-on-bold-100s-unique-ability-to-mitigate-oxaliplatin-induced-peripheral-neuropathy-oipn-302439701.html
03 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/bold-therapeutics-announces-positive-phase-2-safety-and-efficacy-results-for-bold-100-in-advanced-metastatic-biliary-tract-and-gastric-cancers-at-asco-2024-302161951.html
05 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/bold-100-and-atr-inhibitors-as-a-new-avenue-for-pdac-targeting-at-aacr-2024-302108994.html
22 Jan 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/bold-therapeutics-announces-positive-phase-2-safety-and-efficacy-results-for-bold-100-in-advanced-metastatic-colorectal-cancer-at-asco-gi-2024-302040707.html
06 Jun 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/bold-therapeutics-presents-positive-interim-phase-2-results-for-bold-100-in-advanced-gastric-and-biliary-tract-cancer-at-asco-2023-301843600.html
ABOUT THIS PAGE